ОБЗОР

Пожилые пациенты в рандомизированных клинических исследованиях: этические аспекты

Информация об авторах

1 Российский университет дружбы народов, Москва, Россия

2 Городская клиническая больница № 24 Департамента здравоохранения города Москвы, Москва, Россия

Для корреспонденции: Ольга Игоревна Бутранова
ул. Миклухо-Маклая, д. 6, г. Москва, 117198, Россия; ur.ndur@io-avonartub

Информация о статье

Вклад авторов: О. И. Бутранова — анализ литературы, сбор, анализ, написание текста публикации; С. К. Зырянов — анализ, интерпретация данных.

Статья получена: 30.01.2023 Статья принята к печати: 28.02.2023 Опубликовано online: 06.03.2023
|
  1. Le Quintrec JL, Bussy C, Golmard JL, Hervé C, Baulon A, Piette F. Randomized controlled drug trials on very elderly subjects: descriptive and methodological analysis of trials published between 1990 and 2002 and comparison with trials on adults. J Gerontol A Biol Sci Med Sci. 2005; 60 (3): 340–344. DOI: 10.1093/gerona/60.3.340
  2. Konrat C, Boutron I, Trinquart L, Auleley GR, Ricordeau P, Ravaud P. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One. 2012; 7 (3): e33559. DOI: 10.1371/journal.pone.0033559
  3. Lockett J, Sauma S, Radziszewska B, Bernard MA. Adequacy of Inclusion of Older Adults in NIH-Funded Phase III Clinical Trials. J Am Geriatr Soc. 2019; 67 (2): 218–222. DOI: 10.1111/jgs.15786
  4. Prendki V, Tau N, Avni T, et al. A systematic review assessing the under-representation of elderly adults in COVID-19 trials. BMC Geriatr. 2020; 20 (1): 538. Published 2020 Dec 20. DOI: 10.1186/ s12877-020-01954-5
  5. Lam M, Zhu JW, Maqbool T, et al. Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review [published correction appears in JAMA Dermatol. 2020 Nov 1; 156 (11): 1272. JAMA Dermatol. 2020; 156 (11): 1240–1245. DOI: 10.1001/ jamadermatol.2020.2940
  6. Mc Carthy CE, Murphy R, McAteer C, Okon M, O’Donnell M. 279 Inclusion of older patients in clinical trials: a review of a single, high impact, medical journal over a 2-year period. Age Ageing. 2022; 51(Suppl 3): afac218.246. Published 2022 Oct 25. DOI: 10.1093/ageing/afac218.246
  7. Hanlon P, Hannigan L, Rodriguez-Perez J, et al. Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis. BMC Med. 2019; 17 (1): 201. Published 2019 Nov 12. DOI: 10.1186/s12916-019-1427-1
  8. Buttgereit T, Palmowski A, Forsat N, et al. Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials. Age Ageing. 2021; 50 (6): 1988–1996. DOI: 10.1093/ageing/afab147
  9. Altawalbeh SM, Alkhateeb FM, Attarabeen OF. Ethical Issues in Consenting Older Adults: Academic Researchers and Community Perspectives. J Pharm Health Serv Res. 2020; 11 (1): 25–32. DOI: 10.1111/jphs.12327
  10. Lombardo PA. Phantom tumors and hysterical women: revising our view of the Schloendorff case. J Law Med Ethics. 2005; 33 (4): 791–801. DOI: 10.1111/j.1748-720x.2005.tb00545.x
  11. Anweisung an die Vorsteher Der Kliniken, Polikliniken und sonstigen Krankenanstalten über medizinische Eingriffe zu anderen ALS zu diagnostischen, Heilund Immunisierungszwecken vom 29 Dezember 1900. Zentralblatt für die gesamte Unterrichtsverwaltung Preußen 1901. [Accessed December 18, 2018]. Available from: http://goobiweb.bbf.dipf.de/
  12. Mitscherlich A, Mielke F, editors. Medizin Ohne Menschlichkeit Dokumente Des Nürnberger Ärzteprozesses. Frankfurt aM: Fischer Taschenb, 1989.
  13. HHS.gov [homepage on the Internet] The Belmont Report, Ethical Principles and Guidelines for the Protection of Human Subjects of Research. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. [Accessed April 18, 1979]. Available from: http://www.hhs.gov/ohrp/humansubject
  14. Punchik B, Press Y, Samson T. Review of decision-making capacity (DMC) assessment tools for treatment among elderly patients with cognitive imparment. Harefuah. 2020 Sep; 159 (9): 672–677. Hebrew. PMID: 32955810.
  15. Chen KM, Lin JN, Lin HS, et al. The effects of a Simplified Tai-Chi Exercise Program (STEP) on the physical health of older adults living in long-term care facilities: a single group design with multiple time points. Int J Nurs Stud. 2008; 45 (4): 501–507. DOI: 10.1016/j.ijnurstu.2006.11.008
  16. Altawalbeh SM, Alkhateeb FM, Attarabeen OF. Ethical Issues in Consenting Older Adults: Academic Researchers and Community Perspectives. J Pharm Health Serv Res. 2020 Mar; 11(1): 25–32. DOI: 10.1111/jphs.12327. Epub 2019 Oct 30. PMID: 33042231; PMCID: PMC7546426.
  17. Southerland LT, Benson KK, Schoeffler AJ, Lashutka MA, Borson S, Bischof JJ. Inclusion of older adults and reporting of consent processes in randomized controlled trials in the emergency department: A scoping review. J Am Coll Emerg Physicians Open. 2022; 3 (4): e12774. Published 2022 Jul 29. DOI: 10.1002/ emp2.12774
  18. Hempenius L, Slaets JP, Boelens MA, et al. Inclusion of frail elderly patients in clinical trials: solutions to the problems. J Geriatr Oncol. 2013; 4 (1): 26–31. DOI: 10.1016/j.jgo.2012.08.004
  19. Pitkälä KH, Juola AL, Kautiainen H, et al. Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. J Am Med Dir Assoc. 2014; 15 (12): 892–898. DOI: 10.1016/j. jamda.2014.04.002
  20. Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. Br Med J. 2000; 321 (7267): 992–993. DOI: 10.1136/bmj.321.7267.992
  21. Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011; 26 (7): 783–790. DOI: 10.1007/s11606-010-1629-x